RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nucleic acid extraction kits, microbiology media, microbiology stains, and rapid tests; standards and reference materials, and membrane filters; chemicals and reactives, membrane filters, microbiology gas generators, and other consumables; and instruments and consumables. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. was incorporated in 1996 and is based in Kocaeli, Turkey.…
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (RTALB.IS)
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST: RTALB) is listed on Borsa Istanbul, where its shares trade in TRY. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 73 employees.
The shares were at 1.860 TRY on 20 November 2026, down 51.4% over 52 weeks. Its 52-week range is 1.820 TRY to 5.080 TRY: the price is 63.4% below the high and 2.2% above the low.
Its market capitalisation is 930.00M TRY.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. reports return on equity of 29.7%, an operating margin of -5.0% and revenue up 27.2% year over year.
It holds more cash than debt, a net cash position of 56.56M TRY. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.
No upcoming events tracked.